Which component of an enzyme binds to the substrate?

A. All of these choices are correct: Effective antimicrobial drugs must meet several important pharmacologic and microbiologic criteria to ensure therapeutic success. These include selective toxicity toward microbial cells, minimal harmful effects on human tissues, the ability to remain active in body fluids and tissues, and the capacity to reach the site of infection in effective concentrations. Each listed characteristic contributes to the effectiveness and safety of therapy.

B. do not cause serious side effects in humans: One of the essential principles of antimicrobial therapy is selective toxicity, meaning the drug targets microbial structures or metabolic pathways while minimizing harm to host cells. Antimicrobials should produce manageable adverse effects so that treatment can proceed without causing significant injury to the patient.

C. remains active in body tissues and fluids: For an antimicrobial to be effective, it must maintain adequate stability and activity within physiological environments such as blood, tissues, and extracellular fluids. Drugs that remain stable and active in the body are better able to sustain antimicrobial activity against pathogens.

D. readily delivered to the site of infection: Antimicrobial agents must be capable of reaching the infected tissues in sufficient concentrations to inhibit or destroy the pathogen. Barriers such as poor blood supply and tissue inflammation can limit drug delivery. Effective drugs are able to penetrate these tissues or are administered in ways that ensure adequate distribution.

E. high toxicity against microbial cells: Antimicrobial drugs should exert strong inhibitory or lethal effects on microorganisms by targeting structures such as bacterial cell walls, ribosomes, nucleic acids, or metabolic pathways. Selective toxicity allows pathogens to be eliminated while host cells remain largely unaffected. This is characteristic of effective antimicrobial therapy.

When a control agent targets metabolic processes, actively growing and metabolizing cells are more susceptible than older or dormant cells. Younger microbial cells have higher rates of enzyme activity, protein synthesis, and energy production, which are the pathways most affected by metabolic inhibitors. In contrast, older or stationary-phase cells have slowed metabolism and often possess stress adaptations that make them less vulnerable to these agents. Therefore, treatments that disrupt metabolism such as certain antibiotics or chemical disinfectants tend to kill actively dividing cells more rapidly, while non-dividing or metabolically inactive cells survive longer.